$NTR

Nutrien (NYSE:NTR) Upgraded to Sector Outperform at Scotia

Scotia upgraded Nutrien (NTR) from “sector perform” to “sector outperform,” setting an $80 price target (25.97% upside). Other firms adjusted ratings/targets, including Wells Fargo to $100 and UBS to $65. NTR traded at $63.51. Latest quarter: EPS $0.51 vs $0.48; revenue $6.05B vs $5.30B.

Original reporting
Published Jun 30, 2026, 7:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 30, 2026, 7:29 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nutrien (NYSE:NTR) Upgraded to Sector Outperform at Scotia — source image
Decision brief

The 30-second read

$NTRBullishMed
01

Why it matters

The immediate tradable element is the fresh upgrade and target ($80) plus the implied upside (~25.97%) from the article’s stated current price; this can influence short-term positioning and options demand.

02

Market read

A new sell-side upgrade with a quantified target provides a near-term sentiment catalyst, but it lacks new company fundamentals (no new guidance/earnings).

03

What to watch

The article doesn’t add new guidance or operational updates; traders should weigh whether the $80 target is consistent with fertilizer price assumptions and whether the stock’s recent move ($63.51, +$2.33) reflects broader sector strength.

Relevance 7/10Novelty 6/10Timing: Tuesday upgrade note (pre/near-market reaction window)

Background

The piece reports a Scotia analyst rating change for Nutrien and summarizes other recent broker rating/target moves.

Company-level read

Ticker impact

$NTRBullishMedium confidence
Context

Scotia upgraded Nutrien from “sector perform” to “sector outperform” and set an $80 price target, implying ~26% upside from the current price.

Expected impact

Mild-to-moderate upside bias over the next few sessions as traders price in the upgrade; follow-through depends on broader fertilizer/commodity tape.

Evidence & confidence

The article provides a fresh, attributable rating change and target ($80) plus other recent broker actions, but no new company fundamentals beyond previously reported earnings and general financial ratios.

Market effects

Positive read-through for fertilizer/ag-input sentiment, though the catalyst is analyst-driven rather than commodity or demand data.

Canada/commodity-linked equities may see sentiment spillover, but the article is single-name focused.

Limited global impact; fertilizer prices and crop-cycle fundamentals remain the primary drivers beyond this note.

Counterpoint

Multiple brokers have mixed stances (e.g., Zacks cut to hold; UBS reduced target and set sell), so the upgrade may already be partially priced and could fade if commodity/fundamental signals weaken.

Key entities

  • Nutrien

    Global fertilizer and agricultural-services company; subject of the analyst upgrade and price-target update.

  • Scotia

    Upgraded Nutrien from sector perform to sector outperform and set an $80 price target.

Related articles

$NTRMedAI 8/10

TD Securities and Scotiabank Take Different Views on Nutrien (NTR) after Q1 Results

After Nutrien’s Q1 results, TD Securities cut its price target to $83 from $86 and kept a Buy rating, citing expected phosphate margin pressure in Q2. On the same day, Scotiabank raised its target to $80 from $75 and maintained a Sector Perform rating, saying it is more positive despite near-term nitrogen price and regional grower-economics risks. CEO Ken Seitz said record potash volumes and improved Nitrogen/Retail performance supported results.

$NTRMed

2 Dividend Stocks to Hold for the Next 7 Years

The article highlights two TSX dividend stocks for a 7-year hold. Nutrien (NTR) is described as a major crop-input and services provider; it trades near $97, with a 3.1% yield, after a 32% rise in six months. In Q1 2026 it reported net earnings of US$139m and adjusted EBITDA of US$1.1b. South Bow (SOBO) trades at $52.70 (5.2% yield) after a 47% rally; it reported ~616,000 bpd throughput and a 95% operating factor in the March quarter, and expects ~US$10m normalized EBITDA from the Blackrod Conne

$DVAMed

DaVita Shares Rise After TD Cowen Upgrades Stock to Buy

DaVita HealthCare Partners (NYSE:DVA) rose about 2.1% premarket after TD Cowen upgraded it from Hold to Buy and raised its price target to $220 from $201, citing improving competitive position and long-term growth. The upgrade followed DaVita’s Q2 2026 results: adjusted EPS $4.02 vs $3.92 expected, revenue about $3.55B vs estimates, while guidance stayed unchanged.

$ONMed

The Numbers Behind ON Semiconductor’s (ON) Higher Target and Unchanged Hold Rating

ON Semiconductor (NASDAQ:ON) reported stronger-than-expected Q2 earnings and issued Q3 guidance above Wall Street expectations. Robert W. Baird analyst Tristan Gerra raised his price target to $108 from $100 and kept a Neutral rating, citing improving AI data center, industrial, EV and China trends and gross margin guidance of 40% to 42%. He flagged potential market-share losses versus TXN and ST.

$AMZNMed

Bull of the Day: Amazon.com (AMZN)

Amazon.com (AMZN) shares hit new highs after a quarterly report. The company said AWS growth accelerated, margins expanded, and its custom AI chip business reached about a $25B annualized revenue run rate, with advertising growth staying strong. Analysts raised next-year EPS estimates 47.6% to $13.06. AMZN trades at about 20.8x forward earnings and shares rose nearly 25% post-earnings.